High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Based on the average brokerage recommendation (ABR), Alphabet (GOOG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Eli Lilly announced it is buying AtaiBeckley in a bet on neuroscience and psychiatric pharmaceuticals.
Investing.com -- Bernstein raised its price target on ASML Holding NV to €2,500 from €2,300 in a note Thursday, describing the company's second-quarter 2026 results as "triple happiness" following a beat and raise across the top line, capacity and margins.
Every bearish headline about AI spending sends most investors to the sidelines, but one piece of software infrastructure keeps pulling me back to the buy button with growing conviction about where a decade of AI capital is actually flowing.
Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.
The healthcare company posted adjusted earnings of $1.31 a share in the second quarter, topping Wall Street's estimate of $1.28
Micron has surged over 600% in a year on the back of AI-driven memory demand, but three specific cracks in the story suggest new buyers at current prices are underwriting someone else's win.
Eos Energy Enterprises (EOSE) stock is in focus after the company secured a multi-million-dollar Golden Dome for America contract with the U.S. Department of War and issued record preliminary second quarter revenue guidance. See our latest analysis for Eos Energy Enterprises. The Golden Dome contract and record preliminary guidance arrive after a difficult stretch for Eos Energy Enterprises, with the share price down 31.5% over the past month and 66.31% year to date. The 3 year total...
Merck snagged the first-ever approval for a PCSK9 pill to lower LDL cholesterol, starting a new rivalry with injection-makers.
Most income investors fixate on starting yield and overlook the compounding force that actually determines who wins a decade from now. Three large-cap stocks with fresh dividend raises and explicitly committed growth paths could quietly outpace the obvious high-yielders on your watchlist.
McDonald's (MCD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investing.com -- U.S. stock index futures were mixed on Thursday as investors weighed lingering Middle East tensions, and focused on corporate earnings and further signs that U.S. inflationary pressures are easing.
Abbott Laboratories (NYSE:ABT) delivered stronger-than-expected second-quarter results and increased its full-year earnings guidance, sending its shares about 2. 5% higher in premarket trading.
Inference is poised to be the next big AI infrastructure market.
STRL, INOD and LGN are benefiting from AI-driven engineering demand as infrastructure spending and smart project adoption fuel industry growth.
GE Aerospace (NYSE:GE) delivered better-than-expected second-quarter results and upgraded its financial guidance for the full year, supported by continued strength in its commercial services business and improving operational performance. The company reported adjusted earnings of $2.
Investing.com -- Abbott (NYSE:ABT) shares are trading higher premarket on Thursday after the company reported second-quarter earnings, topping consensus expectations and raising its full-year earnings guidance.
Alibaba and Baidu Rally as Apple Expands AI Push in China
The chipmaker guided third-quarter revenue above $45 billion as its 2-nanometer node ramps
Johnson Matthey (LON:JMAT) told shareholders at its 2026 Annual General Meeting that it remains on track with its restructuring plans and medium-term commitments, while highlighting progress on cash generation, portfolio changes and new investments. Opening the meeting, Chair Andy said his first ye
UnitedHealth Stock Rallies as Profit, Revenue Top Wall Street Expectations
The jet engine maker lifted its adjusted EPS forecast to $7.65–$7.85, up from $7.10–$7.40, after revenue climbed 21% in the quarter
By 30 June 2026, total assets under management or supervision stood at $2tn.
Both ATAI and CMPS stocks were among the top trending on Stocktwits in pre-market trade.
Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, continuing the drugmaker’s recent buying spree.
The health insurance giant posted adjusted earnings of $6.38 per share, well above Wall Street estimates, and lifted its full-year adjusted profit guidance to $19.50–$20.00 per share
SpaceX stock has lost altitude recently, creating an opportunity for Cathie Wood’s ARK Invest. ARK is a big believer in Elon Musk. Coming into Thursday trading, SpaceX stock was down for three consecutive days and seven of the past nine days, leaving shares just 27 cents above the $135 IPO price.
They've not been all that magnificent of late, but the sellers behind a few of their recent setbacks seem to have overshot their target.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
